Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.

Source:http://linkedlifedata.com/resource/pubmed/id/20179607

Download in:

View as

General Info

PMID
20179607